Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment

OBJECTIVES: Precise characterization of cognitive outcomes and factors that contribute to cognitive variability will enable better understanding of disease progression and treatment effects in mucopolysaccharidosis type I (MPS I). We examined the effects on cognition of phenotype, genotype, age at e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Genet Metab
Main Authors: Shapiro, Elsa G., Nestrasil, Igor, Rudser, Kyle, Delaney, Kathleen, Kovac, Victor, Ahmed, Alia, Yund, Brianna, Orchard, Paul J., Eisengart, Julie, Niklason, Gregory R., Raiman, Julian, Mamak, Eva, Cowan, Morton J., Bailey-Olson, Mara, Harmatz, Paul, Shankar, Suma P., Cagle, Stephanie, Ali, Nadia, Steiner, Robert D., Wozniak, Jeffrey, Lim, Kelvin O., Whitley, Chester B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4561597/
https://ncbi.nlm.nih.gov/pubmed/26095521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymgme.2015.06.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados